Future Oncology : Impact Factor & More
eISSN: 1744-8301pISSN: 1479-6694
Share this on:
Key Metrics
CiteScore 
4.9
Impact Factor
< 5
SNIP
0.82
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Future Oncology
Future Oncology Journal Specifications
| Overview | |
| Publisher | FUTURE MEDICINE LTD |
| Language | English |
| Frequency | Fortnightly |
| General Details | |
| Language | English |
| Frequency | Fortnightly |
| Publication Start Year | 2005 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Future Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Future Oncology
TROPION-Urothelial03: a phase II/III study of datopotamab deruxtecan (Dato-DXd) for locally advanced or metastatic urothelial carcinoma.
- 16 May 2026
- Future oncology (London, England)
Shared decision-making in prostate cancer treatment: selecting an androgen deprivation therapy option.
- 15 May 2026
- Future oncology (London, England)
SOME: sintilimab plus chemotherapy followed by definitive local therapy for oligometastatic thoracic esophageal squamous cell carcinoma-a multicenter, prospective, open-label phase II trial.
- 15 May 2026
- Future oncology (London, England)
Pexidartinib in patients with tenosynovial giant cell tumor: a plain language summary of the final results from ENLIVEN.
- 14 May 2026
- Future oncology (London, England)
Correction.
- 13 May 2026
- Future oncology (London, England)
The effect of mindfulness-based stress reduction on chemotherapy-related physical and psychological distress in colorectal cancer patients: a retrospective cohort study.
- 13 May 2026
- Future oncology (London, England)
TROPION-Urothelial03: a phase II/III study of datopotamab deruxtecan (Dato-DXd) for locally advanced or metastatic urothelial carcinoma.
- 16 May 2026
- Future oncology (London, England)
Shared decision-making in prostate cancer treatment: selecting an androgen deprivation therapy option.
- 15 May 2026
- Future oncology (London, England)
SOME: sintilimab plus chemotherapy followed by definitive local therapy for oligometastatic thoracic esophageal squamous cell carcinoma-a multicenter, prospective, open-label phase II trial.
- 15 May 2026
- Future oncology (London, England)
Pexidartinib in patients with tenosynovial giant cell tumor: a plain language summary of the final results from ENLIVEN.
- 14 May 2026
- Future oncology (London, England)
Correction.
- 13 May 2026
- Future oncology (London, England)
The effect of mindfulness-based stress reduction on chemotherapy-related physical and psychological distress in colorectal cancer patients: a retrospective cohort study.
- 13 May 2026
- Future oncology (London, England)
FAQs on Future Oncology
How long has Future Oncology been actively publishing? 
What is the publishing frequency of Future Oncology?
How many articles did Future Oncology publish last year?
What is the eISSN & pISSN for Future Oncology?
What is Citescore for Future Oncology?
What is SNIP score for Future Oncology?
Who is the publisher of Future Oncology?
